Committed to developing treatments
for orphan diseases

Laurent Pharmaceuticals is an orphan drug company with a clinical development program in cystic fibrosis.  

laurent Lauren2 Laurent3

Cystic Fibrosis

    Science

 LAU-7b

Events

Laurent Pharmaceuticals to participate at the BioPharm America, September 26-27th 2017, Boston, MA, USA

Laurent Pharmaceuticals to participate at the BIO International Convention, June 19-22th 2017, San Diego, CA, USA

News

Laurent Pharmaceuticals Receives FDA and Health Canada Clearance to Initiate APPLAUD Phase 2 Clinical Study of LAU-7b for the Treatment of Cystic Fibrosis

Read more 

Laurent Pharmaceuticals Receives US$ 3M Development Award From Cystic Fibrosis Foundation Therapeutics

First Canadian Company To Obtain CFFT Therapeutics Development Award

Read more